Literature DB >> 16956984

A virtual reality apartment as a measure of medication management skills in patients with schizophrenia: a pilot study.

Matthew M Kurtz1, Elizabeth Baker, Godfrey D Pearlson, Robert S Astur.   

Abstract

Performance on a novel, virtual reality (VR) assessment of medication management skills, the Virtual Reality Apartment Medication Management Assessment (VRAMMA), was investigated in 25 patients with schizophrenia and 18 matched healthy controls. The VRAMMA is a virtual 4-room apartment consisting of a living room with an interactive clock and TV, a bedroom, a kitchen, and a bathroom with an interactive medicine cabinet. After an exploratory phase, participants were given a mock prescription regimen to be taken 15 minutes later from pill bottles located in the medicine cabinet in the bathroom of the virtual environment. The VRAMMA was administered with a validated measure of medication management skills, several neurocognitive tests, and a symptom scale. Results revealed that (1) schizophrenic patients made significantly more quantitative errors in the number of pills taken, were less accurate at taking the prescribed medications at the designated time, and checked the interactive clock less frequently than healthy controls; (2) in patients with schizophrenia, there was significant agreement in classification of adherence vs nonadherence between a validated measure of medication management skills and the VRAMMA; and (3) in patients with schizophrenia, years of education and a measure of verbal learning and memory were linked to quantitative errors on the VRAMMA, while positive symptoms, specifically delusional symptoms, were inversely linked to distance traveled within the VRAMMA. This is the first study, to our knowledge, to provide evidence for the utility of VR technology in the assessment of instrumental role functioning in patients with schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16956984      PMCID: PMC2632360          DOI: 10.1093/schbul/sbl039

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  24 in total

1.  UCSD Performance-Based Skills Assessment: development of a new measure of everyday functioning for severely mentally ill adults.

Authors:  T L Patterson; S Goldman; C L McKibbin; T Hughs; D V Jeste
Journal:  Schizophr Bull       Date:  2001       Impact factor: 9.306

2.  The Continuous Performance Test, identical pairs version (CPT-IP): I. New findings about sustained attention in normal families.

Authors:  B A Cornblatt; N J Risch; G Faris; D Friedman; L Erlenmeyer-Kimling
Journal:  Psychiatry Res       Date:  1988-11       Impact factor: 3.222

3.  Effectiveness of antipsychotic drugs in patients with chronic schizophrenia.

Authors:  Jeffrey A Lieberman; T Scott Stroup; Joseph P McEvoy; Marvin S Swartz; Robert A Rosenheck; Diana O Perkins; Richard S E Keefe; Sonia M Davis; Clarence E Davis; Barry D Lebowitz; Joanne Severe; John K Hsiao
Journal:  N Engl J Med       Date:  2005-09-19       Impact factor: 91.245

4.  Social skills performance assessment among older patients with schizophrenia.

Authors:  T L Patterson; S Moscona; C L McKibbin; K Davidson; D V Jeste
Journal:  Schizophr Res       Date:  2001-03-30       Impact factor: 4.939

5.  Symptoms and neurocognition as rate limiters in skills training for psychotic patients.

Authors:  T E Smith; J W Hull; S Romanelli; E Fertuck; K A Weiss
Journal:  Am J Psychiatry       Date:  1999-11       Impact factor: 18.112

6.  Construct and concurrent validity of the Hopkins Verbal Learning Test-revised.

Authors:  A M Shapiro; R H Benedict; D Schretlen; J Brandt
Journal:  Clin Neuropsychol       Date:  1999-08       Impact factor: 3.535

Review 7.  Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"?

Authors:  M F Green; R S Kern; D L Braff; J Mintz
Journal:  Schizophr Bull       Date:  2000       Impact factor: 9.306

8.  The relative influences of symptoms, insight, and neurocognition on social adjustment in schizophrenia and schizoaffective disorder.

Authors:  T E Smith; J W Hull; M Goodman; A Hedayat-Harris; D F Willson; L M Israel; R L Munich
Journal:  J Nerv Ment Dis       Date:  1999-02       Impact factor: 2.254

Review 9.  Determinants of medication compliance in schizophrenia: empirical and clinical findings.

Authors:  W S Fenton; C R Blyler; R K Heinssen
Journal:  Schizophr Bull       Date:  1997       Impact factor: 9.306

10.  Improving the accuracy of the diagnosis of schizophrenia by means of virtual reality.

Authors:  Anna Sorkin; Daphna Weinshall; Ilan Modai; Avi Peled
Journal:  Am J Psychiatry       Date:  2006-03       Impact factor: 18.112

View more
  17 in total

1.  Cognitive performance and functional competence as predictors of community independence in schizophrenia.

Authors:  R Walter Heinrichs; Narmeen Ammari; Ashley A Miles; Stephanie McDermid Vaz
Journal:  Schizophr Bull       Date:  2008-07-30       Impact factor: 9.306

Review 2.  Brave new worlds--review and update on virtual reality assessment and treatment in psychosis.

Authors:  Wim Veling; Steffen Moritz; Mark van der Gaag
Journal:  Schizophr Bull       Date:  2014-09-05       Impact factor: 9.306

Review 3.  Measuring Medication Self-Management Capacity: A Scoping Review of Available Instruments.

Authors:  Amal M Badawoud; Teresa M Salgado; Juan Lu; Pamela Parsons; Emily P Peron; Patricia W Slattum
Journal:  Drugs Aging       Date:  2020-07       Impact factor: 3.923

4.  The acceptability and feasibility of a novel virtual reality based social skills training game for schizophrenia: Preliminary findings.

Authors:  Laura H Adery; Megan Ichinose; Lénie J Torregrossa; Joshua Wade; Heathman Nichols; Esube Bekele; Dayi Bian; Alena Gizdic; Eric Granholm; Nilanjan Sarkar; Sohee Park
Journal:  Psychiatry Res       Date:  2018-10-09       Impact factor: 3.222

5.  Beyond the usual suspects: positive attitudes towards positive symptoms is associated with medication noncompliance in psychosis.

Authors:  Steffen Moritz; Jerome Favrod; Christina Andreou; Anthony P Morrison; Francesca Bohn; Ruth Veckenstedt; Peter Tonn; Anne Karow
Journal:  Schizophr Bull       Date:  2012-02-15       Impact factor: 9.306

Review 6.  Standardised assessment of patients' capacity to manage medications: a systematic review of published instruments.

Authors:  Rohan A Elliott; Jennifer L Marriott
Journal:  BMC Geriatr       Date:  2009-07-13       Impact factor: 3.921

7.  Virtual Reality Functional Capacity Assessment In Schizophrenia: Preliminary Data Regarding Feasibility and Correlations with Cognitive and Functional Capacity Performance.

Authors:  Stacy A Ruse; Philip D Harvey; Vicki G Davis; Alexandra S Atkins; Kolleen H Fox; Richard S E Keefe
Journal:  Schizophr Res Cogn       Date:  2014-03

Review 8.  Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia.

Authors:  Jared W Young; Susan B Powell; Victoria Risbrough; Hugh M Marston; Mark A Geyer
Journal:  Pharmacol Ther       Date:  2009-03-06       Impact factor: 12.310

9.  Design of a Virtual Reality System for Affect Analysis in Facial Expressions (VR-SAAFE); Application to Schizophrenia.

Authors:  E Bekele; D Bian; J Peterman; S Park; N Sarkar
Journal:  IEEE Trans Neural Syst Rehabil Eng       Date:  2016-07-14       Impact factor: 3.802

10.  Virtual reality for obsessive-compulsive disorder: past and the future.

Authors:  Kwanguk Kim; Chan-Hyung Kim; So-Yeon Kim; Daeyoung Roh; Sun I Kim
Journal:  Psychiatry Investig       Date:  2009-07-08       Impact factor: 2.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.